CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 375 filers reported holding CRISPR THERAPEUTICS AG in Q1 2023. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,897,302 | -23.5% | 41,800 | -5.4% | 0.00% | -55.6% |
| Q2 2023 | $2,481,388 | +46.3% | 44,200 | +17.9% | 0.01% | -64.0% |
| Q1 2023 | $1,696,125 | -43.4% | 37,500 | -49.1% | 0.02% | -54.5% |
| Q4 2022 | $2,994,198 | +51.8% | 73,658 | +143.9% | 0.06% | +44.7% |
| Q3 2022 | $1,973,000 | +142.1% | 30,200 | +52.1% | 0.04% | -20.8% |
| Q3 2019 | $815,000 | +98.8% | 19,855 | +128.2% | 0.05% | +6.7% |
| Q2 2019 | $410,000 | +24.6% | 8,700 | -5.4% | 0.04% | -16.7% |
| Q1 2019 | $329,000 | – | 9,200 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $32,581,000 | 55.55% |
| NEA Management Company, LLC | 1,590,002 | $103,907,000 | 5.19% |
| ARK Investment Management | 8,237,122 | $538,296,000 | 3.75% |
| Nikko Asset Management Americas, Inc. | 4,262,736 | $277,078,000 | 3.54% |
| CLOUGH CAPITAL PARTNERS L P | 414,767 | $27,105,000 | 2.89% |
| Integral Health Asset Management, LLC | 220,000 | $14,377,000 | 2.79% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,268,000 | 2.48% |
| HC Advisors, LLC | 53,944 | $3,525,000 | 2.43% |
| Green Alpha Advisors, LLC | 27,466 | $1,795,000 | 1.52% |
| EFG Asset Management (North America) Corp. | 84,356 | $5,516,000 | 1.28% |